Journal profile · Hematology
Blood Reviews
ISSN 0268-960X · eISSN 1532-1681 · Churchill Livingstone · ENGLAND · Bimonthly · Founded 1987
Blood Reviews: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 7.07; hybrid open access; APC about USD 5,220; median 82 days to acceptance (99 articles, last 24 months); community-reported acceptance: fairly hard; 63 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Blood Reviews is published by Churchill Livingstone and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Platelet Disorders and Treatments and Lymphoma Diagnosis and Treatment, together about 22.1% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
This respected international journal, Blood Reviews, is a vital information resource, bringing together appraisals of clinical practice, and research from recognized experts. Specially commissioned peer reviewed articles from leading researchers and practitioners guarantee truly global coverage of all the sub-specialties of hematology.Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the Editors welcome suggestions from potential authors. They should first write a brief outline of an intended review along with their publication record on topic and send this to Dr Drew Provan ([email protected]) or to Dr Hillard Lazarus ([email protected]). All articles are subject to peer review. Author queries can also be sent to the Blood Reviews editorial office [email protected]
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editorial board by country: 1 in mainland China (about 3%); most named United States 14, United Kingdom 9, Australia 4, Italy 2, Iran 2 (33 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine8.7%
- Platelet Disorders and TreatmentsMedicine6.8%
- Lymphoma Diagnosis and TreatmentMedicine6.5%
- Chronic Lymphocytic Leukemia ResearchMedicine5.9%
- Hemoglobinopathies and Related DisordersMedicine5.9%
- Hematopoietic Stem Cell TransplantationMedicine5.5%
- Blood groups and transfusionMedicine5.5%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.07LetPub ·
- Impact factor (publisher)
- 7.2Publisher website ·
- CiteScore 2026-06
- 12.7LetPub ·
- CiteScore (publisher)
- 12.7Publisher website ·
- SJR 2026-06
- 2.4LetPub ·
- SNIP 2026-06
- 2.24LetPub ·
- h-index
- 85LetPub ·
- h-index
- 148OpenAlex ·
- i10-index
- 1,232OpenAlex ·
- 2-year mean citedness
- 6.45OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 31.25%LetPub ·
Volume
- Articles per year
- 52LetPub ·
Articles by year OpenAlex count · 1,895 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 43 | 26 | 21 |
| 2025 | 63 | 32 | 338 |
| 2024 | 52 | 31 | 660 |
| 2023 | 71 | 34 | 1,437 |
| 2022 | 67 | 33 | 1,877 |
| 2021 | 61 | 26 | 2,169 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
82 daysMedian, submission to acceptance · P25–P75 64 days – 101 days
- Acceptance to online
- median 2 days (99 articles)
- Submission to online
- median 86 days
- Sample
- 99 articles with submission and acceptance dates (114 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 31 daysPublisher website ·
- Submission to acceptance
- 85 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,220 / EUR 4,880 / GBP 4,180 / JPY 647,440 | — | — | |
| Publisher website | USD 4,910 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 15,000 words
- Highlights
- Optional
Article types accepted6, with length limits
- case reportInvited Reviews: Authors of invited reviews can submit their manuscript to the Editor's via the submission site https://www.editorialmanager.com/bloodreviews/de…Length not stated
- editorialInvited Reviews: Authors of invited reviews can submit their manuscript to the Editor's via the submission site https://www.editorialmanager.com/bloodreviews/de…Length not stated
- invited reviewsInvited Reviews: Authors of invited reviews can submit their manuscript to the Editor's via the submission site https://www.editorialmanager.com/bloodreviews/de…Length not stated
- reviewInvited Reviews: Authors of invited reviews can submit their manuscript to the Editor's via the submission site https://www.editorialmanager.com/bloodreviews/de…Length not stated
- review articleInvited Reviews: Authors of invited reviews can submit their manuscript to the Editor's via the submission site https://www.editorialmanager.com/bloodreviews/de…main text ≤ 15,000 words
- review articlesReview Articles: typically range from 6000-15000 words, 150 word abstract, 6 keywords.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Churchill Livingstone
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1987
- ISSN
- 0268-960X
- Electronic ISSN
- 1532-1681
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Blood Reviews
What CAS zone is Blood Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Blood Reviews is in Zone 2 of Medicine, and in Zone 2 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Blood Reviews?
The latest impact factor listed by LetPub is 7.07; CiteScore 12.7, h-index 148.
How long does peer review take at Blood Reviews?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 82 days (interquartile range 64–101 days); the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Blood Reviews?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 15,000 words; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Blood Reviews based?
Of the 33 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are United States (14), United Kingdom (9) and Australia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Blood Reviews?
According to LetPub and DOAJ records, Blood Reviews is indexed in SCIE and Scopus.
Is Blood Reviews open access, and what is the APC?
Blood Reviews is a hybrid journal. For open-access publication: APC about USD 5,220.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .